课题基金 / 基金详情

FAS Prevention: A Trial of the IOM Model

FAS Prevention: A Trial of the IOM Model
FAS 预防:IOM 模型的试验
批准号:
7048124
负责人:
Philip Alan May
金额:
$100.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2011-08-31

项目摘要

项目成果

Philip Alan May的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The highest rates of fetal alcohol syndrome (FAS) in the world have been found in South Africa (SA) in this town targeted for prevention research. Rates of FAS were 46 and 75 per 1,000 in waves I and II of research and a preliminary rate in Wave III is 79. A high prevalence of FAS exists in other parts of SA. Prevention research has broad implications for programs in SA, the US, and developing populations. This is a multi-site, efficacy trial of a comprehensive, public health model, community-wide, FAS prevention program defined by the Institute of Medicine (IOM). It utilizes both comparative community and pre/post prevention designs with assessment via rigorous diagnosis of FAS in children and infants and also change in drinking practices reflected in measures from a random sample drinking practices survey. Rigorous program evaluation will also assess specific indicated, selected, and universal prevention techniques applied by indigenous workers. Multilevel interventions include: indicated prevention where maternal risk is reduced via: case management of high risk individuals, access to birth control, and enhanced nutrition; brief interventions using principles of motivational interviewing and community reinforcement approach; and individual empowerment/skills building. Selective and universal prevention use: screening for alcohol abuse; targeted messages to change norms and KABB; policy advocacy; and community education and dialogue. The current trial has been modified to begin to address the comorbid condition of HIV/AIDS that is present in the same high-risk women and has many of the same etiological factors predicting adverse pregnancy outcomes. Because this prevention trial is designed as comprehensive and community-wide, there are multiple opportunities for data collection, risk assessment, and evaluation of efficacy of maternal and fetal interventions on both FASD and HIV/AIDS at-risk mothers and their children. The prevention site (urban and rural components) is matched with four comparison communities which will be analyzed in aggregate and as distinct entities to assess confounding influences. Utilizing lOM-recommended techniques of research and prevention applied previously in American Indian communities, this study will determine the efficacy of community-wide prevention of FAS in SA, and which specific components are most viable. Nested studies within the prevention design also address basic research for further specificity of epidemiologic and clinical characteristics of: FAS, adult drinking, and maternal risk factors for FAS. Specific aims are to: 1.) assess the efficacy of the IOM, FAS prevention program; 2.) directly measure the prevention efficacy of the epidemiology "research only" phase via change in age-specific FAS rates; 3.) measure change in adult knowledge, attitudes, beliefs, and drinking behavior (KABB) as well as community readiness for change; 4.) link the level of participation in prevention activities to specific outcomes through process evaluation; 5.) further define maternal risk factors for FAS; and 6.) explore basic issues of risk and protection via nested studies; and 7) examine the prevalence and characteristics of, and risk factors for HIV/AIDS in the Western Cape Province of South Africa including disease progression, AIDS medication availability, and HIV-related fetal outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevalence and Traits of FASD in the US Population: Evidence from Schools
Prevalence and Traits of FASD in the US Population: Evidence from Schools
Prevalence and Traits of FASD in the US Population: Evidence from Schools
海外基金